Discover 2,147 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,147
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
for
Superficial Bladder Cancer,
Location: Philadelphia PA, New Brunswick NJ, Voorhees Township NJ,
Sponsor: enGene, Inc.
Sex: All
Age: 18+
Code: NCT04752722
Phase1, Phase2, Recruiting
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
for
Prostatic Neoplasms
Location: Philadelphia PA, East Brunswick NJ, New York NY,
Sponsor: Janssen Research & Development, LLC
Sex: Male
Age: 18+
Code: NCT06095089
Phase1, Recruiting
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
for
Ovarian Cancer, Breast Cancer, Endometrial Cancer,
Location: Philadelphia PA, Falls Church VA, Pittsburgh PA,
Sponsor: NextCure, Inc.
Sex: All
Age: 18+
Code: NCT06774963
Phase1, Recruiting
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Philadelphia PA, New Brunswick NJ, New York NY,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06297226
Phase2, Recruiting
Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation
Location: Philadelphia PA, Morristown NJ, New Brunswick NJ,
Sponsor: Sumitomo Pharma America, Inc.
Sex: All
Age: 12+
Code: NCT04988555
Phase1, Phase2, Recruiting
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
for
Recurrent Head and Neck Squamous Cell Carcinoma
Location: Philadelphia PA, Providence RI, Tampa FL, Miami FL,
Sponsor: Rakuten Medical, Inc.
Sex: All
Age: 18+
Code: NCT06699212
Phase3, Recruiting
SNV4818 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Philadelphia PA, Boston MA, Toronto, Ottawa,
Sponsor: Pikavation Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06736704
Phase1, Phase2, Recruiting
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Location: Philadelphia PA, Hackensack NJ, Fairfax VA,
Sponsor: NiKang Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06586957
Phase1, Recruiting
A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis
for
Moderate to Severe Atopic Dermatitis
Location: Philadelphia PA, Boardman OH, Plainfield IN,
Sponsor: Sitryx Therapeutics Ltd
Sex: All
Age: 18 - 65
Code: NCT07558668
Phase1, Recruiting
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
for
Non-small Cell Lung Cancer (NSCLC)
Location: Lancaster PA, Newark DE, Hershey PA, Baltimore MD,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07291037
Phase3, Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
for
Triple-Negative Breast Cancer
Location: Philadelphia PA, Newark DE, New York NY, York PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06393374
Phase3, Recruiting
An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Philadelphia PA, New York NY, Fairfax VA, Boston MA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06589596
Phase1, Recruiting
Prospective Breast Cancer Biospecimen Collection
for
Breast Cancer, Invasive Breast Cancer,
Location: Philadelphia PA
Sponsor: Thomas Jefferson University
Sex: All
Age: 18+
Code: NCT04074720
Recruiting
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: Philadelphia PA, Fairfax VA, Durham NC, Nashville TN,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06108050
Phase1, Recruiting
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
for
Recurrent Glioblastoma, IDH-Wildtype,
Location: New Brunswick NJ, Livingston NJ, New York NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05432804
Phase1, Phase2, Recruiting
Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors
for
Liver Neoplasms
Location: Philadelphia PA
Sponsor: john eisenbrey
Sex: All
Age: 18+
Code: NCT06261814
Phase2, Recruiting
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
for
Advanced or Metastatic Solid Tumors, Breast Cancer,
Location: Philadelphia PA, New York NY, New Haven CT, Fairfax VA,
Sponsor: 858 Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06395519
Phase1, Phase2, Recruiting
Computer-Based Continuing Education for Doctors in Examination and Counseling of Patients on Skin Cancer or Weight Control
for
Melanoma (Skin), Non-melanomatous Skin Cancer
Location: Philadelphia PA, Providence RI, Columbus OH, Wichita KS,
Sponsor: Rhode Island Hospital
Sex: All
Age: 18+
Code: NCT00295906
Recruiting
Loncastuximab Tesirine and Rituximab Following Stereotactic Radiosurgery in Patients With Central Nervous System Lymphomas (SOLAR)
for
Central Nervous System Lymphoma
Location: Philadelphia PA, Providence RI, Salt Lake City UT